EP3283086A4 - Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features - Google Patents

Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features Download PDF

Info

Publication number: EP3283086A4
Authority: EP; European Patent Office
Prior art keywords: microbiome; therapeutics; conditions associated; functional features; derived diagnostics
Prior art date: 2015-04-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP16780670.2A

Other languages

German (de)

French (fr)

Other versions

EP3283086A1 (en

Inventor

Zachary APTE

Daniel Almonacid

Jessica RICHMAN

Siavosh Rezvan BEHBAHANI

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Psomagen Inc

Original Assignee

uBiome Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-04-13

Filing date

2016-04-13

Publication date

2019-04-24

2016-04-13Application filed by uBiome IncfiledCriticaluBiome Inc

2018-02-21Publication of EP3283086A1publicationCriticalpatent/EP3283086A1/en

2019-04-24Publication of EP3283086A4publicationCriticalpatent/EP3283086A4/en

StatusWithdrawnlegal-statusCriticalCurrent

Classifications

- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Medical Informatics (AREA)
Life Sciences & Earth Sciences (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Data Mining & Analysis (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Databases & Information Systems (AREA)
Biophysics (AREA)
Theoretical Computer Science (AREA)
Spectroscopy & Molecular Physics (AREA)
Evolutionary Biology (AREA)
Biotechnology (AREA)
Bioinformatics & Computational Biology (AREA)
Biomedical Technology (AREA)
Evolutionary Computation (AREA)
Pathology (AREA)
Chemical & Material Sciences (AREA)
Bioethics (AREA)
Artificial Intelligence (AREA)
Computer Vision & Pattern Recognition (AREA)
Software Systems (AREA)
Primary Health Care (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Analytical Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)

EP16780670.2A2015-04-132016-04-13Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional featuresWithdrawnEP3283086A4 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US201562146833P	2015-04-13	2015-04-13
US201562147202P	2015-04-14	2015-04-14
US201562147077P	2015-04-14	2015-04-14
US201562147058P	2015-04-14	2015-04-14
US201562147334P	2015-04-14	2015-04-14
PCT/US2016/027359WO2016168354A1 (en)	2015-04-13	2016-04-13	Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features

Publications (2)

Publication Number	Publication Date
EP3283086A1 EP3283086A1 (en)	2018-02-21
EP3283086A4true EP3283086A4 (en)	2019-04-24

Family

ID=57126305

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP16780670.2AWithdrawnEP3283086A4 (en)	2015-04-13	2016-04-13	Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features

Country Status (4)

Country	Link
EP (1)	EP3283086A4 (en)
CN (1)	CN107708715B (en)
AU (1)	AU2016250104B2 (en)
WO (1)	WO2016168354A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016168370A1 (en)*	2015-04-14	2016-10-20	uBiome, Inc.	Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions
US20190087536A1 (en)*	2015-09-09	2019-03-21	uBiome. Inc	Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with thyroid health issues
EP3687375A4 (en)*	2016-11-21	2022-01-19	Psomagen, Inc.	Method and system for characterizing a headache-related condition
WO2018112419A1 (en)*	2016-12-15	2018-06-21	uBiome, Inc.	Method and system for characterizing diet-related conditions
EP3775257A4 (en)*	2016-12-15	2022-03-09	Psomagen, Inc.	Method and system for characterizing allergy-related conditions associated with microorganisms
WO2018112459A1 (en)*	2016-12-16	2018-06-21	uBiome, Inc.	Method and system for characterizing microorganism-related conditions
US20200303070A1 (en)*	2017-11-06	2020-09-24	Psomagen, Inc.	Control processes for microorganism-related characterization processes
US20210381054A1 (en)*	2018-10-31	2021-12-09	Coyote Diagnostics Lab (Beijing) Co., Ltd.	Methods, systems and kits for predicting premature birth condition
WO2020131923A1 (en)*	2018-12-17	2020-06-25	uBiome, Inc.	Automatic standardization pipeline for data analysis
WO2022269598A1 (en)*	2021-06-20	2022-12-29	Biotax Labs Ltd.	System and method for predicting a medical condition based on a biological sample
CN114452305B (en)*	2022-03-17	2024-07-26	北京航空航天大学	Application of Bacteroides monothecae in manufacturing drugs for preventing and treating anxiety and depression
CN117409978B (en)*	2023-12-15	2024-04-19	贵州大学	A disease prediction model construction method, system, device and readable storage medium
CN117771278A (en)*	2024-02-26	2024-03-29	四川大学华西医院	Application of Prevotella copri in preparation of medicine for treating senile debilitation syndrome

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20130121968A1 (en)*	2011-10-03	2013-05-16	Atossa Genetics, Inc.	Methods of combining metagenome and the metatranscriptome in multiplex profiles
US20140065132A1 (en)*	2012-08-29	2014-03-06	California Institute Of Technology	Diagnosis and treatment of autism spectrum disorder
WO2014053608A1 (en)*	2012-10-03	2014-04-10	Metabogen Ab	Identification of a person having risk for atherosclerosis and associated diseases by the person's gut microbiome and the prevention of such diseases
WO2015027116A1 (en)*	2013-08-21	2015-02-26	The Regents Of The University Of California	Diagnostic and predictive metabolite patterns for disorders affecting the brain and nervous system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011022660A1 (en)*	2009-08-21	2011-02-24	Puretech Ventures, Llc	Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
BR112013022927A2 (en)*	2011-03-09	2016-12-06	Univ Minnesota	composition, methods for replacing or supplementing or modifying a subject's microbiota of the colon, and for treating a subject, and, use of a composition
AU2014212003C1 (en)*	2013-02-04	2020-07-16	Seres Therapeutics, Inc.	Compositions and methods for inhibition of pathogenic bacterial growth
US10633714B2 (en)*	2013-07-21	2020-04-28	Pendulum Therapeutics, Inc.	Methods and systems for microbiome characterization, monitoring and treatment
US10287637B2 (en)*	2014-01-25	2019-05-14	uBiome, Inc.	Method and system for microbiome analysis

2016
- 2016-04-13EPEP16780670.2Apatent/EP3283086A4/ennot_activeWithdrawn
- 2016-04-13WOPCT/US2016/027359patent/WO2016168354A1/ennot_activeCeased
- 2016-04-13AUAU2016250104Apatent/AU2016250104B2/enactiveActive
- 2016-04-13CNCN201680033974.7Apatent/CN107708715B/enactiveActive

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20130121968A1 (en)*	2011-10-03	2013-05-16	Atossa Genetics, Inc.	Methods of combining metagenome and the metatranscriptome in multiplex profiles
US20140065132A1 (en)*	2012-08-29	2014-03-06	California Institute Of Technology	Diagnosis and treatment of autism spectrum disorder
WO2014053608A1 (en)*	2012-10-03	2014-04-10	Metabogen Ab	Identification of a person having risk for atherosclerosis and associated diseases by the person's gut microbiome and the prevention of such diseases
WO2015027116A1 (en)*	2013-08-21	2015-02-26	The Regents Of The University Of California	Diagnostic and predictive metabolite patterns for disorders affecting the brain and nervous system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references ofWO2016168354A1*

Also Published As

Publication number	Publication date
CN107708715A (en)	2018-02-16
AU2016250104A1 (en)	2017-11-09
WO2016168354A1 (en)	2016-10-20
AU2016250104B2 (en)	2022-02-10
CN107708715B (en)	2022-06-03
EP3283086A1 (en)	2018-02-21

Publication	Publication Date	Title
EP3347495A4 (en)	2019-08-21	Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health
EP3209803A4 (en)	2018-06-13	Method and system for microbiome-derived diagnostics and therapeutics
EP3283086A4 (en)	2019-04-24	Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
EP3317428A4 (en)	2018-12-19	Method and system for diagnostic testing
EP3347496A4 (en)	2019-08-07	Method and system for microbiome-derived diagnostics and therapeutics for oral health
EP3097211A4 (en)	2017-09-20	Method and system for microbiome analysis
EP3164805A4 (en)	2018-01-03	Method and system for selective document redaction
EP3227878A4 (en)	2018-10-03	Method and system for legal parking
GB2528552B (en)	2018-11-14	Vehicle control system and method
EP3145720B8 (en)	2023-04-12	Printing system and method
EP3149698A4 (en)	2017-11-08	Method and system for image georegistration
EP3190864A4 (en)	2017-08-30	Component mounting system and component mounting method
EP3357047A4 (en)	2018-08-08	System and method for scheduling vehicles
GB201417602D0 (en)	2014-11-19	Vehicle control system and method
EP3346912A4 (en)	2019-08-21	Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health
EP3126243A4 (en)	2017-10-11	System and method for improved drive system diagnostics
GB2523184B (en)	2017-01-11	Vehicle control system and method
EP3190434A4 (en)	2018-04-18	Vehicle inspection method and system
EP3273648A4 (en)	2018-03-21	System and method
EP3327402A4 (en)	2018-05-30	Inspection system and inspection method
EP3105965A4 (en)	2017-06-14	System and method for connection rehoming
GB2527089B (en)	2018-08-01	Vehicle control system and method
EP3219558A4 (en)	2018-07-25	Wiper system and wiper system control method
EP3283084A4 (en)	2018-12-19	Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
EP3270179A4 (en)	2018-09-12	Position detecting system and position detecting method

Legal Events

Date	Code	Title	Description
2017-10-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2018-01-19	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text:ORIGINAL CODE: 0009012
2018-01-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: REQUEST FOR EXAMINATION WAS MADE
2018-02-21	17P	Request for examination filed	Effective date:20171020
2018-02-21	AK	Designated contracting states	Kind code of ref document:A1 Designated state(s):AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2018-02-21	AX	Request for extension of the european patent	Extension state:BA ME
2018-07-18	DAV	Request for validation of the european patent (deleted)
2018-07-18	DAX	Request for extension of the european patent (deleted)
2019-01-09	RIC1	Information provided on ipc code assigned before grant	Ipc:G16H 50/70 20180101ALI20181205BHEP Ipc:G06F 19/24 20110101ALI20181205BHEP Ipc:G06F 19/18 20110101AFI20181205BHEP Ipc:A61K 35/741 20150101ALN20181205BHEP Ipc:G16H 50/20 20180101ALI20181205BHEP Ipc:G16H 50/50 20180101ALI20181205BHEP
2019-03-29	REG	Reference to a national code	Ref country code:DE Ref legal event code:R079 Free format text:PREVIOUS MAIN CLASS: A61K0035740000 Ipc:G16H0050500000
2019-04-24	A4	Supplementary search report drawn up and despatched	Effective date:20190322
2019-05-08	RIC1	Information provided on ipc code assigned before grant	Ipc:G16H 50/50 20180101AFI20190329BHEP Ipc:A61K 35/741 20150101ALN20190329BHEP Ipc:G16H 50/20 20180101ALI20190329BHEP Ipc:G16H 50/70 20180101ALI20190329BHEP
2020-03-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2020-04-22	18D	Application deemed to be withdrawn	Effective date:20191022
2020-06-03	19U	Interruption of proceedings before grant	Effective date:20191011
2020-10-07	19W	Proceedings resumed before grant after interruption of proceedings	Effective date:20201201
2020-12-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: REQUEST FOR EXAMINATION WAS MADE
2021-01-06	D18D	Application deemed to be withdrawn (deleted)
2021-01-06	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name:PSOMAGEN, INC.
2023-12-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: EXAMINATION IS IN PROGRESS
2024-01-03	17Q	First examination report despatched	Effective date:20231201
2024-07-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2024-08-21	18D	Application deemed to be withdrawn	Effective date:20240403

Movatterモバイル変換